Navigation Links
FDA To Reconsider Standards for Reviewing Low-Dose Oral Contraceptives

FDA in documents released Thursday announced it is reconsidering its standards for reviewing the failure rate of new oral contraceptives with lower doses// of estrogen and progestin, the Wall Street Journal reports.

According to the Journal, higher pregnancy rates in studies of new low-dose oral contraceptives have instigated the agency to reconsider what represents an "acceptable failure rate" for new drugs. The agency uses a measurement called the Pearl Index, which calculates a contraceptive's failure rate by measuring the amount of time women are exposed to a given product and the number of unplanned pregnancies that result.

According to FDA documents, the agency in the 1970s set a policy that it only approved oral contraceptives with failure rates less than 1.5 per 100 "woman-years," or the number of years a woman has used the drug. FDA has recently approved some pills with failure rates of more than two per 100 woman-years, the Journal reports.

FDA said that the number of pregnancies in clinical trials has increased in new oral contraceptives with lower dosages of estrogen and progestin. The increase in pregnancies is "consistent with less sustained ovulation suppression in new products as compared to the earlier higher dose regimens," but there might be other reasons, FDA said.

Scott Monroe, acting head of the agency's reproductive-drugs division, said the variations between the new contraceptives and the old pills might "not be statistically different." According to the Journal, FDA in an upcoming meeting will seek its advisers' input for new guidelines to review new oral contraceptives.

Source: Kaiser Family Foundation
'"/>




Page: 1

Related medicine news :

1. Reconsideration Of Heart Transplant Eligibility
2. Reconsider Health Benefits of Organic Baby Foods, advices new study
3. Britain Reconsidering New Visa Rules for Indian Doctors
4. Court Orders NHS To Reconsider Funding Lung Cancer Drug
5. Researchers Feel The Need For Standards Of Practice In Immunoglobulin Therapy
6. DMAA to Develop Disease Management Standards by December
7. Setting Standards: Benchmark Medical Tests to Gauge Accuracy of Medical Tests
8. Medical Colleges, Confident of Meeting Standards Before 90-days deadline
9. Cleanliness Standards Dropped In NHS Hospitals – Patient Report
10. International Food Standards Meet Set For Chiang Mai Bangkok
11. Government Warned Against Dilution of Medical Standards
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2017)... ... January 23, 2017 , ... DMG Productions is proud to ... Jr., scheduled to broadcast Saturday, January 28, 2017 at 5:00pmEST. , This segment ... to address the limitations of fatigue monitoring technologies within the mining industry. Today ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... taught by healthcare management and evaluation leaders with decades of experience who remain ... in the United States healthcare system, there is a renewed demand for versatile, ...
(Date:1/23/2017)... Indiana (PRWEB) , ... January 23, 2017 , ... ... Center for Assisted Living (IHCA/INCAL), will serve as a healthcare industry expert at ... 23. The panel discussion, moderated by Inside Indiana Business host Gerry Dick, will ...
(Date:1/23/2017)... ... 23, 2017 , ... Steviva Ingredients, makers of all-natural sweeteners ... National Organic Program (NOP) for its Portland SQF Level 2 manufacturing facility. ... handling systems to complement our current rigorous food-safety management systems,” said Yishu Hou, ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... partnership with the American Society of Anesthesiologists® (ASA®), the Foundation for Anesthesia ... Academy of Orthopaedic Surgeons (AAOS) and the Cigna Foundation, encourages proposals supporting ...
Breaking Medicine News(10 mins):
(Date:1/21/2017)... 20, 2017 ResMed (NYSE: RMD ), BMC ... Winter Haven, Florida ) today announced they have agreed on ... 3B will be permitted to sell their existing products in exchange ... settlement payment to 3B to close the Florida ... an admission of liability or wrongdoing by any party. ...
(Date:1/21/2017)... , Jan. 20, 2017  Today, during ... Conference, "PI3K Pathways in Immunology, Growth Disorders ... (NASDAQ: INFI ) presented preclinical ... candidate that selectively inhibits phosphoinositide-3-kinase-gamma (PI3K-gamma). Preclinical ... help overcome resistance to checkpoint inhibition by ...
(Date:1/20/2017)... -- Research and Markets has announced the addition ... BMP, BUN Creatinine, Electrolyte Testing, HbA1c Testing, Comprehensive Metabolic Panel, Liver ... - 2024" report to their offering. ... The global clinical laboratory testing market ... Introduction of innovative solutions on the grounds of maximum efficiency and ...
Breaking Medicine Technology: